部分活检对原发黑色素瘤复发与生存影响的Meta分析
该Meta分析纳入5项研究共3249例患者,比较部分活检与切除活检对原发黑色素瘤患者无复发生存(RFS)和黑色素瘤相关生存(MRS)的影响。结果显示两组RFS(RR 1.27,95%CI 0.97-1.67,P=0.09)和MRS(RR 1.50,95%CI 0.98-2.30,P=0.06)均无显著差异。结论认为在特殊情况下可进行部分活检而不改变MRS和RFS。
要点
- 部分活检与切除活检相比,黑色素瘤复发风险无显著差异(RR 1.27,P=0.09)。
- 部分活检与切除活检相比,黑色素瘤相关死亡风险无显著差异(RR 1.50,P=0.06)。
- 在特殊情况下(如大型原发肿瘤位于手术敏感区域)可考虑部分活检。
核心结论
- 部分活检可在特殊情况下进行,如大型原发肿瘤位于手术敏感区域,不改变黑色素瘤相关生存和无复发生存。
研究设计与样本
- Meta分析纳入临床试验、观察性队列研究和病例对照研究,共5项研究3249例患者,部分活检组1121例(34.5%),切除活检组2128例(65.5%)。
主要发现
- 无复发生存(RFS)比较:RR 1.27(95%CI 0.97-1.67,P=0.09,随机效应,I2=55%),组间无显著差异。
- 黑色素瘤相关生存(MRS)比较:RR 1.50(95%CI 0.98-2.30,P=0.06,随机效应,I2=60%),组间无显著差异。
临床怎么用
- 在手术敏感区域的大型原发肿瘤等特殊情况下,部分活检可作为切除活检的替代选择,不改变MRS和RFS。
局限性
- 多数研究为回顾性研究。
- 各研究随访时间不统一,且并非均报告随访时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Complete surgical excision is the preferred biopsy type for suspicious melanocytic lesions. However, partial biopsy is sometimes used in special situations. Previous studies have explored the effect of partial biopsy of a primary melanoma on patient outcome with controversial results. OBJECTIVE: We performed a meta-analysis on the influence of the type of biopsy of a primary melanoma on recurrence-free survival (RFS) and melanoma-related survival (MRS). METHODS: Clinical trials, observational cohort studies and case-control studies reporting absolute number of recurrences and/or melanoma-related deaths in patients undergoing a partial or excisional biopsy of melanoma were included in the meta-analysis. RESULTS: In all, the five included studies reported 3249 patients, 1121 (34.5%) of them in the partial biopsy group and 2128 (65.5%) in the excisional biopsy group. Despite a trend in favour of excisional biopsy in reducing the risk for recurrences, the forest plot related to RFS failed to demonstrate significant differences among groups (RR: 1.27; 95% CI 0.97-1.67; P: 0.09; random effects; I2 : 55%). The forest plot showed no difference in the risk of dying for melanoma-related causes for patients undergoing partial biopsy vs. excisions biopsy (RR: 1.50; 95% CI 0.98-2.30; P: 0.06; random effects; I2 : 60%). LIMITATIONS: The majority of the studies were retrospective, and follow-up time was not uniform among studies and not always reported. CONCLUSION: In conclusion, a partial biopsy can be performed in special situations, such as large primary tumours located in surgically sensitive areas, without altering MRS and RFS.
引用
- Moscarella E, Pampena R, Palmiotti G, et al. A meta-analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival. J Eur Acad Dermatol Venereol. 2019. PMID: 31441557. doi:10.1111/jdv.15903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。